Accera logo

Accera

Pioneering breakthroughs in neurodegenerative therapies for Alzheimer’s, Parkinson’s, and age-related memory impairment.

11-50 employees · est. 2001

VS
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd.

RedHill (NASDAQ: RDHL): a pharmaceutical company focused on proprietary drugs for GI and infectious diseases

55 employees · est. 2009 · Raleigh, United States

Accera is the older company (2001 vs 2009); RedHill Biopharma Ltd. is the larger of the two.

Side-by-Side Comparison

Accera RedHill Biopharma Ltd.
Founded
2001 older 2009
Headquarters
Not tracked yet Raleigh, United States
Employees
11-50 55 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series Unknown Post Ipo Equity
Total Funding
$196.22M $92.95M
Funding Rounds
7 8
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Neurodegenerative Diseases, Therapeutic Drugs, Alzheimer's, Parkinson's, Memory Impairment, Ketasyn, Drug Discovery, Drug Development Pharmaceuticals, Biopharmaceuticals, Drug Development, Gastrointestinal Diseases, Infectious Diseases, Clinical Development, Technology Platforms, Management Team, Board Of Directors, Advisory Board, Israel, U.S., Canada, Europe, Specialty Drugs
Website
accerapharma.com redhillbio.com
Accera logo

About Accera

Accera, established in 2001 and based in Broomfield, Colorado, is a pioneering biotechnology firm in the fields of neurodegenerative therapies for Alzheimer’s, Parkinson’s, and age-related memory impairment. The company is focused on the discovery and development of therapeutic drugs aimed at neurod...

RedHill Biopharma Ltd. logo

About RedHill Biopharma Ltd.

RedHill Biopharma Ltd. Slogan: RedHill (NASDAQ: RDHL): a pharmaceutical company focused on proprietary drugs for GI and infectious diseases Description: RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases and infectious diseas...

We will tell you when either one moves

BounceWatch watches Accera and RedHill Biopharma Ltd. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Accera and RedHill Biopharma Ltd. — by email.

Frequently Asked Questions

Accera — Pioneering breakthroughs in neurodegenerative therapies for Alzheimer’s, Parkinson’s, and age-related memory impairment.. RedHill Biopharma Ltd. — RedHill (NASDAQ: RDHL): a pharmaceutical company focused on proprietary drugs for GI and infectious diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Accera has raised $196.22M while RedHill Biopharma Ltd. has raised $92.95M.
Accera and RedHill Biopharma Ltd. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Accera with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Accera on 12 Sep 2024, and RedHill Biopharma Ltd. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy